TB-500 is a synthetic peptide derived from a naturally occurring protein known as thymosin beta-4. In research settings, TB-500 has been studied for its potential role in supporting cellular migration, tissue repair processes, angiogenesis, and recovery following injury. Researchers have investigated its effects on muscle, tendon, ligament, and connective tissue models due to its ability to influence actin regulation and cellular movement. TB-500 is intended for laboratory research purposes only and is not approved for human consumption or therapeutic use.
———————————————
FOR RESEARCH USE ONLY: KareTides TB-500 is supplied strictly for in-vitro laboratory research and analytical purposes only. It is explicitly not intended for human consumption, diagnostic, or therapeutic applications. By purchasing, you agree that you are an authorized researched operating within a qualified facility.
TB-500 is a synthetic peptide derived from a naturally occurring protein known as thymosin beta-4. In research settings, TB-500 has been studied for its potential role in supporting cellular migration, tissue repair processes, angiogenesis, and recovery following injury. Researchers have investigated its effects on muscle, tendon, ligament, and connective tissue models due to its ability to influence actin regulation and cellular movement. TB-500 is intended for laboratory research purposes only and is not approved for human consumption or therapeutic use.
———————————————
FOR RESEARCH USE ONLY: KareTides TB-500 is supplied strictly for in-vitro laboratory research and analytical purposes only. It is explicitly not intended for human consumption, diagnostic, or therapeutic applications. By purchasing, you agree that you are an authorized researched operating within a qualified facility.
Interested in acquiring this peptide for research purposes? To begin the ordering process, please visit our contact page and submit the inquiry form. A member of our team will review your request and follow up with additional information and next steps.
